The loss of STAT5 in liver cells reverses the pathological changes associated with chronic inflammation caused by the overactivation of GH signaling; however, it leads to the earlier occurrence of liver cancer with a more aggressive phenotype. This evidence concerns the gene GH1 and liver cancer.